Leap Therapeutics Inc. buy BiotechBee
Start price
07.01.24
/
50%
€3.70
Target price
30.09.25
€5.00
Performance (%)
-47.57%
Price
18.07.24
€1.94
Summary
This prediction is currently active. The BUY prediction by BiotechBee for Leap Therapeutics Inc. is performing very badly with a performance of -47.57%. This prediction currently runs until 30.09.25. The prediction end date can be changed by BiotechBee at any time. BiotechBee has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Leap Therapeutics Inc. | 6.593% | 6.593% |
iShares Core DAX® | -0.543% | 1.491% |
iShares Nasdaq 100 | -2.696% | -1.235% |
iShares Nikkei 225® | -2.863% | 2.491% |
iShares S&P 500 | -1.105% | 0.013% |
According to BiotechBee what are the pros and cons of Leap Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Leap Therapeutics Inc diskutieren
Buy mit Kursziel 5,0